Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.accesswire.com/854830/biophytis-announces-ratio-change-under-its-american-depositary-receipt-adr-program
https://www.accesswire.com/854309/biophytis-announces-new-scientific-advisory-board-for-its-phase-2-oba-clinical-study-in-obesity
https://www.accesswire.com/851281/biophytis-announces-its-2023-financial-results-and-provides-an-update-on-its-business-activities
https://www.accesswire.com/851279/biophytis-launches-oba-phase-2-clinical-study-in-obesity-with-bio101-20-hydroxyecdysone
https://www.accesswire.com/850340/results-of-the-combined-general-meeting-on-april-2-2024
https://www.accesswire.com/845737/biophytis-presented-its-phase-3-protocol-in-the-treatment-of-sarcopenia
https://www.biophytis.com/en/biophytis-and-skyepharma-sign-a-partnership-agreement-for-the-production-of-sarconeos-bio101/
https://www.biophytis.com/en/update-on-early-access-programs-for-sarconeos-bio101-in-the-treatment-of-severe-forms-of-covid-19/
https://www.biophytis.com/en/appointment-of-edouard-bieth-as-chief-business-officer/
https://www.biophytis.com/en/replay-25th-annual-h-c-wainwright-global-investment-conference/